explore -WSS

explore

author：focus 2025-09-30 22:03:39 - browse：4

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Merck, Johnson & Johnson CEOs will testify on high drug prices

WSS

Why Medicare shouldn’t cover every FDA

White House pharmacy plagued with problems, investigation finds

Investment in vaccine development is lagging, report finds

How should state employee insurance handle Wegovy?

FTC sues over Novant Health acquisition of two N.C. hospitals

Why you shouldn’t ask, “What country has the best health care?”

hotspot

explore

Wikipedia

Alkermes shareholders re

Why Medicare shouldn’t cover every FDA

Medical records are filled with copy

The Affordable Care Act has saved billions in health care costs

Tori Bowie and the unacceptable rates of Black maternal death

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Novavax promises a turnaround & Lilly roils the obesity market

10 reasons why health care startups fail

ChatGPT in medicine: STAT answers readers' burning questions

STAT Readout: Today's biotech news includes Sana and Amylyx

focus

Humana’s losses in Medicare Advantage tank its stock

Zyn nicotine pouches become unlikely player in latest culture war

Pancreatic cancer early detection could be helped by AI

Zyn nicotine pouches become unlikely player in latest culture war

Vertex non

A fraught question for the kids of Alzheimer’s: Is it coming for us?

entertainment

hotspot

knowledge

focus